Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/Evidence/397483 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: Evidence_for_Results_for_Systolic_blood_pressure_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#397483, OID:2.16.840.1.113883.4.642.40.44.22.83 | |||||
Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/ |
|||||
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
version: 4; Last updated: 2025-09-13 18:20:05+0000
identifier: FEvIR Object Identifier/397483, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.83
version: 1.0.0-ballot3
name: Evidence_for_Results_for_Systolic_blood_pressure_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan
title: Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan
citeAs:
Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397483. Revised 2025-09-13. Available at: https://fevir.net/resources/Evidence/397483. Computable resource at: https://fevir.net/resources/Evidence/397483#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Brian S. Alper, MD, MSPH:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Type | Target[x] |
| Part Of | Outcome Measure Report for QUARTET USA Trial |
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
variableRole: Population
observed: the study group
variableDefinition
variableRole: Exposure
variableDefinition
variableRole: Outcome
observed: Systolic blood pressure at 12 weeks
statistic
statisticType: difference in means
quantity: -4.5 mm Hg
SampleSizes
Extension NumberOfParticipants KnownDataCount 62 53 attributeEstimate
type: confidence interval
level: 0.95
range: -10.82-1.32 mm Hg
attributeEstimate
type: p-value
quantity: 0.123
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-snapshot1.
Generated
2026-11-05
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change